A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf
.
Interventions for Visceral Adiposity Associated with Human Immunodeficiency Virus: Application of a Method for Assessing Efficacy
2003
Clinical Infectious Diseases
In addition to lipoatrophy of the subcutaneous fat compartment and lipohypertrophy of the breasts and dorsocervical fat pad, excess visceral fat is considered to be part of human immunodeficiency virus (HIV)-associated lipodystrophy. Because of associations between visceral adiposity and atherosclerotic risk and undesirable clinical and psychological effects, therapies for this morphological alteration are under investigation. The non-HIV literature on the visceral fat effects of various
doi:10.1086/375880
pmid:12942381
fatcat:gxoklxanmfcelghdohoq2yxxje